NR4A1 and ductal breast carcinoma in situ: IBIS‐II (DCIS), a double‐blind randomized placebo‐controlled trial, involved 2980 postmenopausal patients with hormone receptor‐positive DCIS, treated with conservative breast surgery (BCS) with or without RT.